Lv1
100 积分 2021-12-17 加入
CML-1199: Targeting Chronic Myeloid Leukemia: Meta-Analytic Evaluation of Dasatinib Versus High-Dose Imatinib Outcomes and Toxicities
2个月前
已关闭
256eP Chemotherapy retreatment versus regorafenib in third-line metastatic colorectal cancer: Survival outcomes, prognostic model, and toxicity profile
2个月前
已关闭
Cardiovascular Events Associated with CDK4/6 Inhibitors: A Safety Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database
10个月前
已完结
皖公网安备34019202002308
